Accretive Health Names Steve Shulman as Chairman of the Board
April 04 2014 - 7:30AM
Business Wire
Accretive Health, Inc. (OTC Pink: ACHI) today announced that
Steve Shulman, an independent member of the Company’s Board of
Directors since April 2013, has been elected Chairman of the Board
of Directors effective April 2, 2014. This follows Mary Tolan’s
previously announced decision to step down as Chairman of the
Board. Ms. Tolan will continue to serve as a director of the
Company through Accretive Health’s 2014 annual meeting of
shareholders.
“I am honored to take on this role as Chairman,” said Mr.
Shulman. “Our Board and leadership team have been working to
strengthen Accretive Health’s foundation to ensure that we are well
positioned to capture the growth opportunities emerging in the face
of ongoing industry change. We have made significant progress
toward becoming current in our financials, and at the same time,
have made operational improvements that are helping us to build a
stronger client-centric culture. I look forward to continuing to
work with the Company’s Board and leadership team to continue our
important work.”
“Over the past year, Steve has been an invaluable resource to
the Company,” said Steve Schuckenbrock, president and chief
executive officer of Accretive Health. “He brings more than 40
years of experience in the healthcare industry as well as
significant leadership and operational expertise. As Chairman,
Steve’s leadership will be vital as we continue to implement our
strategy to serve our clients in a dynamic and evolving healthcare
marketplace and help ensure the sustainability of their patient
care missions.”
“In ten years, we have grown Accretive Health from a startup to
a Company that serves the leading names in healthcare across the
country, and I believe now is the right time to make this
transition,” Ms. Tolan said. “I am confident that Steve is the
right leader as Chairman to position Accretive Health for its next
chapter of growth and success. I look forward to continuing to
serve on the Board through the annual meeting and to following the
Company’s success well into the future.”
Accretive Health added four new Board members in 2013,
including: Mr. Shulman, Alex J. Mandl, Robert V. Stanek and current
president and chief executive officer Steve Schuckenbrock.
Steve Shulman
Steve Shulman most recently served as the chairman of the board
of Health Management Associates, where he oversaw the company’s
successful sale to Community Health, which closed this past
January. He is the former chairman and chief executive officer of
Magellan Health Services, Inc., where he spearheaded the company’s
successful turnaround and restructuring out of bankruptcy, and
diversification into the nation’s foremost specialty healthcare
management company. He also led Prudential Healthcare through its
major turnaround while serving as the company’s chairman, president
and CEO, culminating in the company’s successful sale to Aetna.
Steve is the co-founder of Value Health, Inc., a NYSE managed care
company, specializing in behavioral health and prescription drug
benefits. He also founded Internet HealthCare Group, an early-stage
health and technology venture fund. Previously, he held leadership
roles at CIGNA and Kaiser Permanente. In addition to serving as
Chairman of Accretive Health, Steve serves as the chairman of
Access MediQuip and CareCentrix. He also serves as a director of
Facet Technologies, Health Markets, MedImpact and Oasis
Outsourcing. Steve has been recognized for his leadership including
being named one of the top CEOs in the managed care industry by
Institutional Investor Magazine. He received his bachelor’s degree
in economics and master’s degree in health services administration
from the State University of New York at Stony Brook.
About Accretive Health
At Accretive Health, our mission is to partner with healthcare
communities to serve as a catalyst for a healthier future for all.
For more information, visit www.accretivehealth.com.
Safe Harbor
This press release contains forward-looking statements,
including the Company’s statements regarding its ability to
complete its restatement and make required SEC filings, and
statements regarding the Company’s strategic initiatives. All
forward-looking statements contained in this press release involve
risks and uncertainties. Our actual results and outcomes could
differ materially from those anticipated in these forward-looking
statements as a result of various factors, including the
possibility that any restatement that may be required could have
unanticipated consequences and the factors set forth in our
Quarterly Report on Form 10-Q for the quarter ended September 30,
2012, filed with the SEC on November 8, 2012, under the heading
“Risk Factors”. The words “strive,” “objective,” “anticipates,”
“believes,” “estimates,” “expects,” “intends,” “may,” “plans,”
“projects,” “would,” and similar expressions are intended to
identify forward-looking statements, although not all
forward-looking statements contain these identifying words. The
Company has based these forward-looking statements on its current
expectations and projections about future events. Although the
Company believes that the expectations underlying any of its
forward-looking statements are reasonable, these expectations may
prove to be incorrect and all of these statements are subject to
risks and uncertainties. Should one or more of these risks and
uncertainties materialize, or should underlying assumptions,
projections, or expectations prove incorrect, actual results,
performance, financial condition, or events may vary materially and
adversely from those anticipated, estimated, or expected.
All forward-looking statements included in this press release
are expressly qualified in their entirety by these cautionary
statements. The Company cautions readers not to place undue
reliance on any forward-looking statement that speaks only as of
the date made and to recognize that forward-looking statements are
predictions of future results, which may not occur as anticipated.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the uncertainties and factors described above, as well as others
that the Company may consider immaterial or does not anticipate at
this time. Although the Company believes that the expectations
reflected in its forward-looking statements are reasonable, the
Company does not know whether its expectations may prove correct.
The Company’s expectations reflected in its forward-looking
statements can be affected by inaccurate assumptions it might make
or by known or unknown uncertainties and factors, including those
described above. The risks and uncertainties described above are
not exclusive, and further information concerning the Company and
its business, including factors that potentially could materially
affect its financial results or condition or relationships with
customers and potential customers, may emerge from time to time.
The Company assumes no, and it specifically disclaims any,
obligation to update, amend, or clarify forward-looking statements
to reflect actual results or changes in factors or assumptions
affecting such forward-looking statements. The Company advises
investors, however, to consult any further disclosures it makes on
related subjects in our periodic reports that it files with or
furnishes to the SEC.
Accretive Health, Inc.Investor Relations:Atif Rahim,
312-324-5476investorrelations@accretivehealth.comorMedia
Relations:Joele Frank, Wilkinson Brimmer KatcherAndrea Rose or
Mahmoud Siddig, 212-355-4449
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
R1 RCM (NASDAQ:RCM)
Historical Stock Chart
From Sep 2023 to Sep 2024